| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $963.0M | -5.0% |
| Cost of Revenue | $637.3M | -0.2% |
| Gross Profit | $325.7M | -13.1% |
| R&D Expense | $23.9M | -8.9% |
| SG&A Expense | $107.2M | +0.5% |
| Operating Income | $54.6M | -49.1% |
| Interest Expense | $32.4M | -14.6% |
| Pre-tax Income | -$5.5M | -108.9% |
| Income Tax | -$367K |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.7M | -53.0% |
| Accounts Receivable | $165.5M | -3.3% |
| Inventory | $198.6M | +6.7% |
| Current Assets | $465.8M | -9.4% |
| Total Assets | $1.74B | -4.8% |
| Current Liabilities | $257.9M | -1.5% |
| Long-term Debt | $458.7M | -11.3% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.6M | -32.1% |
| Capital Expenditures | $21.4M | -13.7% |
| Investing Cash Flow | -$19.9M | +85.1% |
| Financing Cash Flow | -$86.7M | -280.0% |
| Free Cash Flow | $24.2M | -42.9% |
| -102.5% |
| Net Income | -$5.1M | -111.0% |
| EPS (Basic) | -$0.18 | -111.1% |
| EPS (Diluted) | -$0.18 | -111.2% |
| Total Liabilities |
| $856.7M |
| -9.2% |
| Stockholders' Equity | $882.1M | +0.0% |